title: Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.
authors.forename: O M
authors.initials: OM
authors.lastname: Escobosa Sánchez
authors.forename: A
authors.initials: A
authors.lastname: Herrero Hernández
authors.forename: M J
authors.initials: MJ
authors.lastname: Ortega Acosta
authors.forename: J
authors.initials: J
authors.lastname: Camacho Alonso
authors.forename: G
authors.initials: G
authors.lastname: Milano Manso
authors.forename: T
authors.initials: T
authors.lastname: Acha García
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy*; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006440:Hemofiltration; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D012516:Osteosarcoma / Q000097:blood / Q000188:drug therapy*; D013977:Tibia; D011623:gamma-Glutamyl Hydrolase / Q000600:supply & distribution / Q000627:therapeutic use
chemical_list: D004317:Doxorubicin; D011623:gamma-Glutamyl Hydrolase; D002945:Cisplatin; D007069:Ifosfamide; D008727:Methotrexate